论文部分内容阅读
目的:探索肺结核患者接受抗结核治疗的具体方法以及治疗效果,为临床疾病的治疗提供有力的依据。方法:选取我院在以往二年之内所接诊的肺结核患者资料100例开展对比分析,根据治疗方案的差异将所选患者进行分组,给予对照组患者常规抗结核药物治疗,给予研究组患者胸腺肽+常规抗结核药物联合治疗,比较研究组和对照组患者的治疗效果。结果:研究组患者治疗效果显著高于对照组,患者肺结核症状消失时间、药物起效时间以及肺部病变恢复时间显著短于对照组,两组比较存在统计学意义(P<0.05)。结论:临床中针对肺结核患者,加用胸腺肽联合抗结核治疗效果明显,应该给予大力的推广与应用。
Objective: To explore the tuberculosis patients receiving anti-TB treatment of specific methods and therapeutic effect, provide a strong basis for the treatment of clinical diseases. Methods: A total of 100 patients with tuberculosis admitted in our hospital in the past two years were enrolled in this study. The patients were divided into groups according to the difference of treatment regimen, and the patients in the control group were given conventional antituberculous drugs. Patients in the study group Thymosin combined with conventional antituberculosis drugs, the treatment effect of the study group and the control group were compared. Results: The treatment effect of the study group was significantly higher than that of the control group. The time of symptom disappearance, the onset time of the drug and the recovery time of pulmonary lesion in the study group were significantly shorter than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: In the clinical treatment of patients with pulmonary tuberculosis, combined with thymosin combined with anti-TB treatment is obvious, should be given a strong promotion and application.